EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring Plant-Derived Natural Products as Potential Therapeutic Agents Against Cancer

Ayu Lestari Wijaya, Muhammad Fadli Rahman

Emerging Pharmaceutical Sciences and Innovation · 27.09.2026 · 1 (1) · 15-26

DOI: 10.53623/epsi.v1i1.1309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Emerging Pharmaceutical Sciences and Innovation, online erschienen am 27.09.2026. Verfasst von Ayu Lestari Wijaya und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer continues to impose a substantial global health burden, highlighting the urgent need for effective, targeted, and economically accessible therapeutic agents. Medicinal plants offer a valuable source of chemically diverse natural products with considerable potential for anticancer drug discovery. Several plant-derived compounds have successfully entered clinical practice, including vinca alkaloids, taxanes, camptothecin-based drugs, and podophyllotoxin derivatives. This review critically examines recent advances in the discovery, purification, structural identification, and therapeutic development of phytochemicals with anticancer properties. Particular attention is given to traditional and advanced extraction technologies, chromatographic separation procedures, and spectroscopic techniques employed to identify and characterize biologically active constituents. The review further evaluates major groups of plant secondary metabolites, including alkaloids, flavonoids, phenolic compounds, terpenoids, and saponins, with emphasis on their anticancer activities and underlying molecular mechanisms. Emerging strategies to improve therapeutic performance and clinical applicability are also explored, particularly nanoscale drug delivery systems, biotechnological approaches for sustainable compound production, and computational methods for identifying promising drug candidates. Furthermore, critical limitations associated with bioavailability, selectivity, toxicity, production scalability, and clinical translation are discussed alongside prospective research priorities. An integrated radial workflow illustration and four comparative tables are incorporated to provide a systematic overview of the progression from phytochemical extraction and molecular characterization to preclinical evaluation and potential clinical application.

Zitieren

APA

Wijaya, A. L., & Rahman, M. F. (2026). Exploring Plant-Derived Natural Products as Potential Therapeutic Agents Against Cancer. Emerging Pharmaceutical Sciences and Innovation, 1(1), 15-26. https://doi.org/10.53623/epsi.v1i1.1309

Vancouver

Wijaya AL, Rahman MF. Exploring Plant-Derived Natural Products as Potential Therapeutic Agents Against Cancer. Emerging Pharmaceutical Sciences and Innovation. 2026;1(1):15-26. doi:10.53623/epsi.v1i1.1309

BibTeX
@article{Wijaya2026,
  author = {Wijaya, Ayu Lestari and Rahman, Muhammad Fadli},
  title = {Exploring Plant-Derived Natural Products as Potential Therapeutic Agents Against Cancer},
  journal = {Emerging Pharmaceutical Sciences and Innovation},
  year = {2026},
  volume = {1},
  number = {1},
  pages = {15--26},
  doi = {10.53623/epsi.v1i1.1309}
}
Kostenlos starten →